Overview
Lihong Cao practices in Hangzhou, China. Cao is rated as an Advanced expert by MediFind in the treatment of Lymphofollicular Hyperplasia. Their top areas of expertise are Lymphofollicular Hyperplasia, Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), and Non-Hodgkin Lymphoma.
Their clinical research consists of co-authoring 8 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Lymphofollicular Hyperplasia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lymphofollicular Hyperplasia
- Experienced
- Mast Cell Activation Syndrome (MCAS)
- Non-Hodgkin LymphomaCao isExperienced. Learn about Non-Hodgkin Lymphoma.
- Precocious PubertyCao isExperienced. Learn about Precocious Puberty.
- Systemic MastocytosisCao isExperienced. Learn about Systemic Mastocytosis.